Aldeyra Therapeutics, Inc. (NASDAQ:ALDX – Get Free Report) CEO Todd Brady acquired 250,000 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average cost of $1.67 per share, for a total transaction of $417,500.00. Following the completion of the transaction, the chief executive officer directly […]

Chemomab Therapeutics Ltd. Sponsored ADR (NASDAQ:CMMB – Get Free Report) shot up 4.7% during trading on Thursday . The company traded as high as $1.84 and last traded at $1.80. 31,693 shares were traded during mid-day trading, a decline of 35% from the average session volume of 48,497 shares. The stock had previously closed at […]